Automation of simplified two-step radiolabeling via ditosylate synthon for 18F-labeled radiotracers using AllinOne module
- PMID: 39277961
- PMCID: PMC11714026
- DOI: 10.1016/j.nucmedbio.2024.108948
Automation of simplified two-step radiolabeling via ditosylate synthon for 18F-labeled radiotracers using AllinOne module
Abstract
Direct fluorination of a tosylate or mesylate precursor has been a wide-spread and reliable way for radio-fluorination. This approach can be difficult to achieve when the precursor cannot be easily obtained or is chemically unstable. A possible alternative method is to radiolabel ethylene ditosylate or 1,3-propanediol di-p-tosylate to form a radiofluorinated synthon. Here we present the automation of a simplified and reliable approach for the two-step fluorination using [18F]FP-TMP, an analog of antibacterial agent trimethoprim. We demonstrate the feasibility of purifying the fluorinated synthon via filtration, and one final HPLC purification on a commercially available Trasis AllinOne module. The overall reaction time for the two-step reaction is around 90 min andthe decay-corrected yield for more than fifty preparations of [18F]FP-TMP is 22 ± 5 % with high radiochemical purity (≥ 90 %) and specific activities (147 ± 107 GBq/μmol). All batches passed pre-established quality control specifications, demonstrating the utility of using this method in tracer syntheses that meet good manufacturing practice (GMP) requirement. This method can be adopted to the syntheses of other radiotracers, such as [18F]FE-TMP, (+)-[18F]F-PHNO and [18F]FFMZ.
Keywords: AllinOne; Automation; PET; Radiotracer; Two-step fluorination.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest Mark Sellmyer and Robert Mach have filed US patent US20180104365A1, assigned to the University of Pennsylvania, on radiotracer derivatives of trimethoprim for medical imaging. Both hold equity in Vellum Biosciences, a corporate entity that is commercializing trimethoprim radiotracers. Hsiaoju Lee has a consulting agreement with Vellum Biosciences. All others have no conflict of interest.
Figures



Similar articles
-
Fully Automated Cassette-Based Production of [18F]Albumin Using the Trasis AllinOne Module.J Labelled Comp Radiopharm. 2025 Jul;68(9-10):e4153. doi: 10.1002/jlcr.4153. J Labelled Comp Radiopharm. 2025. PMID: 40616327
-
"In-loop" 18 F-fluorination: A proof-of-concept study.J Labelled Comp Radiopharm. 2019 Jun 15;62(7):292-297. doi: 10.1002/jlcr.3751. J Labelled Comp Radiopharm. 2019. PMID: 31083778
-
Fully automated production of the fibroblast activation protein radiotracer [18 F]FAPI-74.J Labelled Comp Radiopharm. 2021 Jun 30;64(8):346-352. doi: 10.1002/jlcr.3926. Epub 2021 May 29. J Labelled Comp Radiopharm. 2021. PMID: 34050679
-
Synthesis modules and automation in F-18 labeling.Ernst Schering Res Found Workshop. 2007;(62):289-316. doi: 10.1007/978-3-540-49527-7_11. Ernst Schering Res Found Workshop. 2007. PMID: 17172160 Review.
-
Fluorine-18 radiochemistry, labeling strategies and synthetic routes.Bioconjug Chem. 2015 Jan 21;26(1):1-18. doi: 10.1021/bc500475e. Epub 2014 Dec 12. Bioconjug Chem. 2015. PMID: 25473848 Free PMC article. Review.
References
-
- Luengo O, Galvan-Blasco P, Cardona V. Molecular diagnosis contribution for personalized medicine. Curr Opin Allergy Clin Immunol 2022;22:175–80. - PubMed
-
- Sharma S. PET radiopharmaceuticals for personalized medicine. Curr Drug Targets 2016;17:1894–907. - PubMed
-
- Mach RH, Schwarz SW. Challenges for developing PET tracers: isotopes, chemistry, and regulatory aspects. PET Clin 2010;5:131–53. - PubMed
-
- Nerella SG, Bhattacharya A, Thacker PS, Tulja S. Synthetic methodologies and PET imaging applications of fluorine-18 radiotracers: a patent review. Expert Opin Ther Pat 2022;32:455–73. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources